MIR548AV

Across TCGA pan-cancer cohorts, MIR548AV RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR548AV data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR548AV RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548AV expression acts as an unfavorable survival marker, although some lineages such as STAD and ESCA show a favorable association.

BLCA, BRCA, and KIRC are the cancer types where MIR548AV RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.183	0.711	<.001	135	view →
BRCA	OS	Tertile	III,IV	0.211	0.833	<.001	36	view →
KIRC	DFS	Tertile	IV	0.170	0.624	.004	36	view →
THCA	OS	Tertile	II,III,IV	0.250	0.893	<.001	36	view →
KIRP	DFS	Tertile	II,III,IV	0.519	0.770	<.001	33	view →
LGG	DFS	Tertile	All	0.508	0.775	.001	21	view →
STAD	DFS	Tertile	IV	1.000	0.279	.029	18	view →
SARC	DFS	Tertile	All	0.109	0.611	.030	18	view →
LUAD	OS	Tertile	II,III,IV	0.196	0.681	.004	18	view →
ESCA	OS	Tertile	III,IV	1.000	0.377	.025	15	view →
SKCM	DFS	Tertile	All	0.226	0.757	.037	9	view →
GBM	OS	Tertile	All	0.089	0.415	.037	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MIR548AV–BLCA (OS)

Open the BLCA breakdown →